Tumor Biology

, Volume 37, Issue 9, pp 11893–11901 | Cite as

Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion

  • Mengyou Li
  • Xin Li
  • Shiming Xu
  • Pengfei Xue
  • QingZhe Li
  • Qingyang Lu
  • Qingbin Jia
  • Lianqun Zhang
  • Xueyuan Li
  • Xingang Li
Original Article

Abstract

Protein phosphatase 4 catalytic subunit (PP4C) has been identified to be overexpressed in various solid cancers. However, to date, the role of PP4C in glioma remains elusive. In the present study, we aimed to detect PP4C expression in glioma patients and explore its function in glioma and prognostic significance in patients with glioma. The expression levels of PP4C mRNA and protein in 30 glioma tissue specimens and 10 non-cancerous brain tissue specimens were detected by qRT-PCR and Western blot analysis. Moreover, immunohistochemistry was performed to assess PP4C expression in 120 glioma patients. The effects of siRNA-mediated PP4C silencing on the proliferation, migration, and invasion of U251 and U87 glioma cells were assessed. We found that PP4C was upregulated in glioma tissue at both mRNA and protein levels compared with non-cancerous brain tissue. Univariate and multivariate analyses indicated that high PP4C expression was an independent prognostic factor for poor survival of glioma patients. Knockdown of PP4C reduced the proliferation, migration, and invasion of U251 and U87 cells. In conclusion, our findings suggest that PP4C plays an oncogenic role in glioma development and progression and might serve as a prognostic biomarker as well as a potential therapeutic target for glioma.

Keywords

Glioma PP4C Prognosis Biomarker 

Notes

Acknowledgments

The project was supported by the National Natural Science Foundation of China (No. 81372721) and Natural Science Foundation of Shandong Province (No. ZR2013HM011).

Compliance with ethical standards

This study was approved by Ethics Committee of Liaocheng People’s Hospital and Qilu Hospital. Written informed consent was obtained from all the patients.

Conflicts of interest

None

References

  1. 1.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Moorhead GB, Trinkle-Mulcahy L, Ulke-Lemee A. Emerging roles of nuclear protein phosphatases. Nat Rev Mol Cell Biol. 2007;8:234–44.CrossRefPubMedGoogle Scholar
  3. 3.
    Lipinszki Z, Lefevre S, Savoian MS, Singleton MR, Glover DM, Przewloka MR. Centromeric binding and activity of protein phosphatase 4. Nat Commun. 2015;6:5894.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Toyo-oka K, Mori D, Yano Y, Shiota M, Iwao H, Goto H, et al. Protein phosphatase 4 catalytic subunit regulates cdk1 activity and microtubule organization via ndel1 dephosphorylation. J Cell Biol. 2008;180:1133–47.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Xie Y, Juschke C, Esk C, Hirotsune S, Knoblich JA. The phosphatase pp4c controls spindle orientation to maintain proliferative symmetric divisions in the developing neocortex. Neuron. 2013;79:254–65.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Liao FH, Shui JW, Hsing EW, Hsiao WY, Lin YC, Chan YC, et al. Protein phosphatase 4 is an essential positive regulator for treg development, function, and protective gut immunity. Cell Biosci. 2014;4:25.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Theobald B, Bonness K, Musiyenko A, Andrews JF, Urban G, Huang X, et al. Suppression of ser/thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death. Molecular cancer research : MCR. 2013;11:845–55.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Lee DH, Acharya SS, Kwon M, Drane P, Guan Y, Adelmant G, et al. Dephosphorylation enables the recruitment of 53bp1 to double-strand DNA breaks. Mol Cell. 2014;54:512–25.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Yeh PY, Yeh KH, Chuang SE, Song YC, Cheng AL. Suppression of mek/erk signaling pathway enhances cisplatin-induced nf-kappab activation by protein phosphatase 4-mediated nf-kappab p65 thr dephosphorylation. J Biol Chem. 2004;279:26143–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Zhou G, Boomer JS, Tan TH. Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1. J Biol Chem. 2004;279:49551–61.CrossRefPubMedGoogle Scholar
  11. 11.
    Bertram PG, Choi JH, Carvalho J, Ai W, Zeng C, Chan TF, et al. Tripartite regulation of Gln3p by TOR, Ure2p, and phosphatases. J Biol Chem. 2000;275:35727–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Wang B, Zhao A, Sun L, Zhong X, Zhong J, Wang H, et al. Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res. 2008;18:974–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Weng S, Wang H, Chen W, Katz MH, Chatterjee D, Lee JE, et al. Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2012;21:1336–43.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Li X, Liang L, Huang L, Ma X, Li D, Cai S. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Mol Cancer. 2015;14:95.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer genetics. 2012;205:613–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Hu MC, Tang-Oxley Q, Qiu WR, Wang YP, Mihindukulasuriya KA, Afshar R, et al. Protein phosphatase x interacts with c-Rel and stimulates c-Rel/nuclear factor kappab activity. J Biol Chem. 1998;273:33561–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Knight LM, Stakaityte G, Wood JJ, Abdul-Sada H, Griffiths DA, Howell GJ, et al. Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration. J Virol. 2015;89:35–47.CrossRefPubMedGoogle Scholar
  18. 18.
    Lee DH, Pan Y, Kanner S, Sung P, Borowiec JA, Chowdhury D. A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination. Nat Struct Mol Biol. 2010;17:365–72.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shaltiel IA, Aprelia M, Saurin AT, Chowdhury D, Kops GJ, Voest EE, et al. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci U S A. 2014;111:7313–8.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, et al. A PP4-phosphatase complex dephosphorylates gamma-h2ax generated during DNA replication. Mol Cell. 2008;31:33–46.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Rosales KR, Reid MA, Yang Y, Tran TQ, Wang WI, Lowman X, et al. Tiprl inhibits protein phosphatase 4 activity and promotes h2ax phosphorylation in the DNA damage response. PLoS ONE. 2015;10, e0145938.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Lee J, Adelmant G, Marto JA, Lee DH. Dephosphorylation of DBC1 by protein phosphatase 4 is important for p53-mediated cellular functions. Mol Cells. 2015;38:697–704.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Mengyou Li
    • 1
    • 2
  • Xin Li
    • 1
    • 2
  • Shiming Xu
    • 3
  • Pengfei Xue
    • 2
  • QingZhe Li
    • 4
  • Qingyang Lu
    • 5
  • Qingbin Jia
    • 2
  • Lianqun Zhang
    • 2
  • Xueyuan Li
    • 2
  • Xingang Li
    • 1
  1. 1.Department of NeurosurgeryQilu Hospital of Shandong UniversityJinanChina
  2. 2.Department of NeurosurgeryLiaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical UniversityLiaochengChina
  3. 3.Department of RadiologyLiaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical UniversityLiaochengChina
  4. 4.Liaocheng People’s Hospital and Clinical School of Taishan Medical UniversityLiaochengChina
  5. 5.Department of PathologyLiaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical UniversityLiaochengChina

Personalised recommendations